Top Research Reports For Merck, DISH & Pioneer Natural

 | Nov 10, 2016 12:44AM ET

Thursday, November 10 2016

The Zacks Research Daily report showcases part of our analyst team's daily research output. Our analyst team publishes fresh research reports on more than 70 stocks daily, of which we have featured 16 in today's write-up, including reports on Merck (NYSE:MRK), DISH Network (NASDAQ:DISH) and Pioneer Natural Resources (PXD). You can see the complete list of today's research reports here >>

Merck shares have handily outperformed the broad pharma space, with the stock up more than 21% year-to-date, on the back of strong momentum in its product pipeline. The company's better than expected Q3 results and positivie guidance are adding to the momentum as well. The analyst likes Merck’s new products, especially Keytruda, which should continue to contribute meaningfully to the top line. The latest FDA approval of Keytruda for the first line treatment of metastatic lung cancer should sharply improve the drug’s sales. Merck has also made significant progress with its pipeline and is working on bringing new products to the market. However, generic competition and pricing pressure will continue to pressurize the top line. (You can )

DISH Network shares have been strong performers lately, reflecting greater appreciation for the company's diversification efforts and its valuable spectrum assets. DISH is in the process of diversifying away from operating as a pure-play satellite-TV operator to an Internet TV operator, which should help it weather competitive threats from low-cost video streaming operators. The company is poised to benefit from its Internet TV service – Sling TV – which offers services at a reasonable rate. However, DISH Network’s top line may remain under pressure as the company’s failure to strike any deal with wireless operators is a major headwind. (You can )

Pioneer Natural’s shares have surged, increasing by more than 41% year-to-date. The analyst likes Pioneer Natural Resources’ joint venture in the southern Wolfcamp acreage, which is helping to accelerate activities in the area. The company’s successful cost-containment efforts and low level of debts are other positives. These show the efficiency in its operations and place it advantageously over its peers. All these positives are reflected in the company’s massive year-over-year improvement in third-quarter 2016 earnings. However, the bottom line missed expectations due to persistent low oil price, which remains as overhang on the stock. (You can >>)

Other noteworthy reports we are featuring today include Johnson Controls (NYSE:JCI), Philips (PHG) and Boston Properties (NYSE:BXP).

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Free Access: All Zacks Research Reports
Starting today, you are invited to download in-depth analysis reports covering more than 1,000 of the most widely followed stocks. Valued at $25 each, they are yours to consult over the next 30 days absolutely free. They feature sensitive Zacks Rank information on each stock that you won't find anywhere else. See the reports free >>

Sheraz Mian

Director of Research

Note: If you want an email notification each time Sheraz publishes a new article, please >>>

Today's Must Read/h6

Featured Reports/h6

The Zacks analyst believes that Ameren Corp.'s better-than-expected results were driven by higher infrastructure investments made by its units under the modern, constructive regulatory frameworks.

The covering analyst believes Macerich's better-than-expected results were driven by improvement in releasing spread and same center net operating income.

The Zacks analyst believes that headwinds like weak coal demand and delayed grain harvest hurt Canadian Pacific's Q3 results. However, the company's efforts to control costs are encouraging.

Philips' Q3 earnings grew 17.7% year over, braving volatility in key end markets. The covering analyst thinks the company's diligent "change-initiative" programs bode well for future growth.

The Zacks analyst thinks International Flavors & Fragrances holds strong long-term growth potential, but is exposed to near-term risks.

The Zacks analyst thinks Boston Properties' concentration of assets in only five U.S. markets adversely affects its operations.

The covering analyst believes Mohawk's current investment to further expansion and acquisition will drive growth.

New Upgrades/h6

American Public's adjusted earnings and revenues beat expectations. The Zacks analyst thinks recent investment in enrollment management leadership and strategic relationships will drive enrollments.

The covering analyst believes signs of improving coal fundamentals will gradually boost coal demand and subsequently increase Natural Resource's coal royalty revenues.

The Zacks analyst is impressed by the company's Q4 sales beat and the year over year increase in earnings and revenues. The company's proposal to hike its quarterly dividend is also a positive.

New Downgrades/h6

Johnson Controls has spun off of its Automotive Interiors business into an independent company, Adient. The Zacks analyst thinks deconsolidation of this business and negative currency translation is hurting sales.

The covering analyst thinks soft demand for paper based office products due to technological advancements and stiff competition from online retailers affected Staples third-quarter 2016 performance.

Q3 results were hurt due to weak steel prices, low capital spending and poor demand. Strong U.S. dollar and stiff business rivalry also weighed on quarterly results.

Zacks Investment Research

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes